Phase I trial of CJRB-101 plus pembrolizumab in patients with metastatic non-small cell lung cancer, head and neck squamous cell carcinoma and melanoma
J. Immunother. Cancer, May 15 2026, 14 (5) e014702 | https://doi.org/10.1136/jitc-2025-014702
A Phase 2 Study of Stereotactic Ablative Radiotherapy Plus Atezolizumab Plus Tiragolumab in Treatment-naïve Patients with Advanced Non-small Cell Lung Cancer
Clin. Cancer Res., Apr 20 2026, | https://doi.org/10.1158/1078-0432.CCR-25-4990